Schreurs MW - Search Results

1

Melanocyte lineage-specific antigen gp100 is recognized by melanoma-derived tumor-infiltrating lymphocytes.

Bakker AB, Schreurs MW, de Boer AJ, Kawakami Y, Rosenberg SA, Adema GJ, Figdor CG. Bakker AB, et al. Among authors: schreurs mw. J Exp Med. 1994 Mar 1;179(3):1005-9. doi: 10.1084/jem.179.3.1005. J Exp Med. 1994. PMID: 8113668 Free PMC article.

2

Identification of a novel peptide derived from the melanocyte-specific gp100 antigen as the dominant epitope recognized by an HLA-A2.1-restricted anti-melanoma CTL line.

Bakker AB, Schreurs MW, Tafazzul G, de Boer AJ, Kawakami Y, Adema GJ, Figdor CG. Bakker AB, et al. Among authors: schreurs mw. Int J Cancer. 1995 Jul 4;62(1):97-102. doi: 10.1002/ijc.2910620118. Int J Cancer. 1995. PMID: 7541395 Free article.

3

Transcription of the gene encoding melanoma-associated antigen gp100 in tissues and cell lines other than those of the melanocytic lineage.

Brouwenstijn N, Slager EH, Bakker AB, Schreurs MW, Van der Spek CW, Adema GJ, Schrier PI, Figdor CG. Brouwenstijn N, et al. Among authors: schreurs mw. Br J Cancer. 1997;76(12):1562-6. doi: 10.1038/bjc.1997.597. Br J Cancer. 1997. PMID: 9413942 Free PMC article.

4

Cloning, expression and tissue distribution of the murine homologue of the melanocyte lineage-specific antigen gp100.

Schreurs MW, de Boer AJ, Schmidt A, Figdor CG, Adema GJ. Schreurs MW, et al. Melanoma Res. 1997 Dec;7(6):463-70. doi: 10.1097/00008390-199712000-00004. Melanoma Res. 1997. PMID: 9464618

5

Genetic vaccination against the melanocyte lineage-specific antigen gp100 induces cytotoxic T lymphocyte-mediated tumor protection.

Schreurs MW, de Boer AJ, Figdor CG, Adema GJ. Schreurs MW, et al. Cancer Res. 1998 Jun 15;58(12):2509-14. Cancer Res. 1998. PMID: 9635569

6

Biodistribution and vaccine efficiency of murine dendritic cells are dependent on the route of administration.

Eggert AA, Schreurs MW, Boerman OC, Oyen WJ, de Boer AJ, Punt CJ, Figdor CG, Adema GJ. Eggert AA, et al. Among authors: schreurs mw. Cancer Res. 1999 Jul 15;59(14):3340-5. Cancer Res. 1999. PMID: 10416590

7

Generation and functional characterization of mouse monocyte-derived dendritic cells.

Schreurs MW, Eggert AA, de Boer AJ, Figdor CG, Adema GJ. Schreurs MW, et al. Eur J Immunol. 1999 Sep;29(9):2835-41. doi: 10.1002/(SICI)1521-4141(199909)29:09<2835::AID-IMMU2835>3.0.CO;2-Q. Eur J Immunol. 1999. PMID: 10508258 Free article.

8

The renal cell carcinoma-associated antigen G250 encodes a human leukocyte antigen (HLA)-A2.1-restricted epitope recognized by cytotoxic T lymphocytes.

Vissers JL, De Vries IJ, Schreurs MW, Engelen LP, Oosterwijk E, Figdor CG, Adema GJ. Vissers JL, et al. Among authors: schreurs mw. Cancer Res. 1999 Nov 1;59(21):5554-9. Cancer Res. 1999. PMID: 10554034

9

Heterogeneous expression of the SSX cancer/testis antigens in human melanoma lesions and cell lines.

dos Santos NR, Torensma R, de Vries TJ, Schreurs MW, de Bruijn DR, Kater-Baats E, Ruiter DJ, Adema GJ, van Muijen GN, van Kessel AG. dos Santos NR, et al. Among authors: schreurs mw. Cancer Res. 2000 Mar 15;60(6):1654-62. Cancer Res. 2000. PMID: 10749136

10

Dendritic cell-based vaccines: from mouse models to clinical cancer immunotherapy.

Schreurs MW, Eggert AA, Punt CJ, Figdor CG, Adema GJ. Schreurs MW, et al. Crit Rev Oncog. 2000;11(1):1-17. Crit Rev Oncog. 2000. PMID: 10795625 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

177 results

Search Page

Filters